What We're Reading: Page 138
Industry reads hand-picked by our editors
Dec 14, 2021
-
The Washington Post
Democrats’ plan to cap insulin prices faces GOP threat, skeptical advocates
-
STAT
Moderna, Amgen among biotech heavyweights pulling out of JPM conference over Covid concerns
-
Nature
Antibody–oligonucleotide conjugates enter the clinic
-
The New York Times
Merck’s Covid Pill Might Pose Risks for Pregnant Women
Dec 13, 2021
-
The Wall Street Journal
The Big Vaccine Pivot: Merck Falters on Covid-19 Shots, Then Makes One for Rival J&J
-
The Boston Globe
‘This is confusing the hell out of us.’ No one knows how Omicron originated, but scientists have theories
-
STAT
Roche two-armed antibody posts strong tumor responses in lymphoma study, rivaling CAR-T therapy
-
Endpoints News
Eli Lilly's Van Naarden hands $380M cash to Flagship-backed upstart in major new oncology deal
Dec 10, 2021
Dec 09, 2021
Dec 08, 2021
Dec 07, 2021
-
C&EN
Another year of pharma
-
Endpoints News
Meet 20 extraordinary women who are supercharging biopharma R&D
-
The New York Times
Biden Focuses on How Spending Bill Would Lower Drug Costs
-
The San Diego Union-Tribune
Richard Lerner, who led Scripps Research to greatness, dies at 83
Dec 06, 2021
-
The Wall Street Journal
Hedge Funds Suffer Big Losses on Biotech Rout
-
The Wall Street Journal
How a Vaccine Side-Effect Database Sowed Doubt in Vaccinations
-
The Washington Post
Gilead recalls vials of its Remdesivir covid drug in U.S. over glass contamination
-
Axios
Drug pricing coalition documents reveal data-blocking against employers
Previous
